한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

in recent years, alibaba's strategic layout has become increasingly clear, from the "internet" of the digital economy to the "digitalization" of the medical field, gradually moving towards more precise fields. as alibaba's digital marketing platform, alimama has marketing products such as search, display, and information flow for all consumers, providing merchants with full-link business solutions. this injection of alimama's health assets will directly promote the profitability of ali health and focus more on the expansion of b-side business.

shen difan's return is undoubtedly a sign of ali health's "correction". he once led ali health to build a strong c-end influence, but eventually had to give up the o2o business. this injection means that ali health will return to the b-end marketing field and further deepen the construction of the medical ecosystem through resource integration.

this is not only a new strategic layout, but also reflects alibaba's emphasis on and investment in the future medical industry. from the failure of the "yilu" platform to shen difan's return, ali health has been exploring and learning, and finally found the right direction. the alimama assets injected this time are not just the use of digital marketing tools, but reflect ali health's deep understanding and vision of the future medical ecosystem, which also means that ali health will challenge the market again and compete with other medical platforms.

the future of healthcare will usher in a new competitive landscape. from the perspective of ali health, it is actively exploring and planning, trying to play its own advantages in the digital age. with the return of shen difan and the injection of alimama's business, ali health will usher in new development opportunities and achieve greater success.